Britain's competition watchdog has fined Pfizer a record $106 million for its role in ramping up the cost of an epilepsy drug by as much as 2,600 percent.
USATODAY - Money Top Stories, USA Today: Money
Thu, 12/08/2016 - 8:19am
Britain's competition watchdog has fined Pfizer a record $106 million for its role in ramping up the cost of an epilepsy drug by as much as 2,600 percent.